Literature DB >> 23184816

Lipid A from lipopolysaccharide recognition: structure, dynamics and cooperativity by molecular dynamics simulations.

Jose Antonio Garate1, Chris Oostenbrink.   

Abstract

Molecular dynamics simulations of Lipid A and its natural precursor Lipid IVA from E.coli have been carried out free in solution, bound to the myeliod differentiation protein 2 (MD2) and in the complex of MD2 with the toll like receptor 4 (TLR4). In addition, simulations of the ligand free MD2 and MD2-TLR4 complex were performed. A structural and energetic characterization of the bound and unbound states of Lipid A/IVA was generated. As the crystal structures depict, the main driving force for MD2-Lipid A/IVA are the hydrophobic interactions between the aliphatic tails and the MD2 cavity. The charged phosphate groups do strongly interact with positively charged residues, located at the surface of MD2. However, they are not essential for keeping the lipids in the cavity, indicating a more prominent role in binding recognition and ionic interactions with TLR4 at the MD2/TLR4 interface. Interestingly, in the absence of any ligand MD2 rapidly closes, blocking the binding cavity. The presence of TLR4, though changing the dynamics, was not able to impede the aforementioned closing event. We hypothesize that fluctuations of the H1 region are essential for this phenomenon, and it is plausible that an equilibrium between the open and closed states exists, although the lengths of our simulations are not sufficient to encompass the reversible process. The MD2/Lipid A-TLR4 complex simulations show that the presence of the ligand energetically stabilizes the complex relative to the ligand-free structures, indicating cooperativity in the binding process.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23184816     DOI: 10.1002/prot.24223

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  11 in total

1.  Atomistic Scale Effects of Lipopolysaccharide Modifications on Bacterial Outer Membrane Defenses.

Authors:  Amy Rice; Jeff Wereszczynski
Journal:  Biophys J       Date:  2018-03-27       Impact factor: 4.033

2.  The structural basis for endotoxin-induced allosteric regulation of the Toll-like receptor 4 (TLR4) innate immune receptor.

Authors:  Teresa Paramo; Thomas J Piggot; Clare E Bryant; Peter J Bond
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

3.  Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.

Authors:  Jose Antonio Garate; Johannes Stöckl; María del Carmen Fernández-Alonso; Daniel Artner; Mira Haegman; Chris Oostenbrink; Jesús Jiménez-Barbero; Rudi Beyaert; Holger Heine; Paul Kosma; Alla Zamyatina
Journal:  Innate Immun       Date:  2014-11-13       Impact factor: 2.680

4.  Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid differentiation protein 2.

Authors:  Weitao Fu; Lingfeng Chen; Zhe Wang; Chengwei Zhao; Gaozhi Chen; Xing Liu; Yuanrong Dai; Yuepiao Cai; Chenglong Li; Jianmin Zhou; Guang Liang
Journal:  Drug Des Devel Ther       Date:  2016-01-27       Impact factor: 4.162

5.  A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach.

Authors:  Masaud Shah; Muhammad Ayaz Anwar; Dhanusha Yesudhas; Jayalakshmi Krishnan; Sangdun Choi
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

6.  Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.

Authors:  Kelsey A Gregg; Erin Harberts; Francesca M Gardner; Mark R Pelletier; Corinne Cayatte; Li Yu; Michael P McCarthy; Jason D Marshall; Robert K Ernst
Journal:  mBio       Date:  2017-05-09       Impact factor: 7.867

7.  Structure-Activity Relationship in TLR4 Mutations: Atomistic Molecular Dynamics Simulations and Residue Interaction Network Analysis.

Authors:  Muhammad Ayaz Anwar; Sangdun Choi
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

8.  Design and Development of a Novel Peptide for Treating Intestinal Inflammation.

Authors:  Lulu Zhang; Xubiao Wei; Rijun Zhang; Jim N Petitte; Dayong Si; Zhongxuan Li; Junhao Cheng; Mengsi Du
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

9.  Structure and dynamic behavior of Toll-like receptor 2 subfamily triggered by malarial glycosylphosphatidylinositols of Plasmodium falciparum.

Authors:  Prasannavenkatesh Durai; Rajiv Gandhi Govindaraj; Sangdun Choi
Journal:  FEBS J       Date:  2013-10-16       Impact factor: 5.542

10.  C-Terminal Amination of a Cationic Anti-Inflammatory Peptide Improves Bioavailability and Inhibitory Activity Against LPS-Induced Inflammation.

Authors:  Lulu Zhang; Xubiao Wei; Rijun Zhang; Matthew Koci; Dayong Si; Baseer Ahmad; Henan Guo; Yanfei Hou
Journal:  Front Immunol       Date:  2021-02-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.